Market Research Reports

Biosensors Market (Technologies: Electrochemical, Optical, Thermal, Piezoelectric; Applications: Medical, Food Toxicity Detection, Industrial Process Control, Agriculture, Environment and Others; and End Users: Point of Care Testing, Home Healthcare Diagnostics, Research Laboratories, Security and Bio-defense, and Food Industry) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

101pages
Published Date: 2014-11-17
 

Description



This report on the biosensors market studies the current as well as future prospects of the market globally. Biosensors are rapidly gaining popularity in the global market due to its wide array of applications in the fields of medical diagnostics, pharmaceuticals, food industry, bio-defense, and industrial processes. The largest application for biosensors since their origin continues to be blood glucose monitors. However, the market is now demonstrating a paradigm shift towards various other applications such as infectious disease monitoring, blood gas analyses, cholesterol testing, pregnancy testing and non-medical applications such as industrial biology, food toxicity detection and military services. Biosensors are now also being positioned for cancer detection and personalized medicine due to its accurate detection of specific biological analyte and reliable imaging of cancer cells. This report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the biosensors market. It also provides information and data analysis of the global biosensors market with respect to market segments based on the type of biosensor technology, applications, end users and their geographic markets. 

Based on technology, the biosensors market is segmented into four major segments: electrochemical, optical, piezoelectric and thermal. Similarly, based on application, the market has been segmented into medical, food toxicity detection, industrial process control, agriculture, environment and others (bio-defense, drug abuse prevention). The biosensors market has also been segmented on the basis of end users which includes point of care testing, home healthcare diagnostics, research laboratories, security and bio-defense, and food industry. The market segments have been extensively analyzed based on their usefulness, efficacy, revenue and geographic coverage. The market size and forecast in terms of USD million for each market segment has been provided for the period from 2012 to 2020. The report also provides the compounded annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2020, considering 2013 as the base year.
Geographically, the biosensors market has been categorized into four regions: North America, Europe, Asia Pacific, and Rest of the World (RoW). The market size and forecast for each of these regions has been provided for the period from 2012 to 2020, along with their respective CAGRs for the forecast period from 2014 to 2020, considering 2013 as the base year. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, Porter’s five forces analysis and the key players’ market share analysis in 2013 in order to present a thorough analysis of the overall competitive scenario in the global biosensors market. 

A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market and thereby establish a foothold. The report also profiles major players of the biosensors market on the basis of various attributes such as company overview, financial overview, business strategies, product portfolio and recent developments. Major players profiled in this report include Abbott Point of Care, Inc., Medtronic, Inc., LifeScan, Inc., F. Hoffmann-La Roche Ltd., AgaMatrix, Inc., Animas Corporation, LifeSensors, Inc., Siemens Healthcare and Nova Biomedical Corporation.

The global biosensors market is segmented as follows:

Biosensors Market, by Technologies
  • Electrochemical
  • Optical
  • Thermal
  • Piezoelectric
Biosensors Market, by Applications
  • Medical 
  • Food Toxicity Detection
  • Industrial Process Control
  • Agriculture
  • Environment
  • Others (Bio-defense, drug abuse prevention etc.)
Biosensors Market, by End Users
  • Point of Care Testing
  • Home Healthcare Diagnostics
  • Research Laboratories
  • Security and Bio-defense
  • Food Industry
Biosensors Market, by Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the World (RoW)

Table of Contents



Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Biosensors Market
2.2 Comparative Analysis: Global Biosensors Market Revenue, by Geography, 2013 & 2020 (Value %)

Chapter 3 Global Biosensors Market Overview
3.1 Introduction
3.2 Market Drivers
     3.2.1 Increase in Diabetic Population Leading to Growth of Diagnostic Devices Using Biosensor Technology
     3.2.2 Large Number of Medical Applications of Biosensors Expected to Fuel Market Growth
     3.2.3 High Demand for Miniaturization of Diagnostic Devices Contributing to the Growth of the Novel Biosensors Market
3.3 Market Restraints
     3.3.1 High Costs Involved in R&D Likely to Hinder Market Growth
     3.3.2 Unfavorable Reimbursement Policies have Hampered the Growth of the Biosensors Market
3.4 Market Opportunities
     3.4.1 Development of Non-invasive Biosensors would Provide a Ladder for Growth
3.5 Porter’s Five Forces Analysis: Global Biosensors Market
     3.5.1 Bargaining Power of Suppliers
     3.5.2 Bargaining Power of Buyers
     3.5.3 Threat of Substitutes
     3.5.4 Threat of New Entrants
     3.5.5 Competitive Rivalry
3.6 Value Chain Analysis: Global Biosensors Market
3.7 Market Attractiveness Analysis: Global Biosensors Market, by Geography

Chapter 4 Global Biosensors Market, by Technology
4.1 Overview
     4.1.1 Global Biosensors Market Revenue, by Technology, 2012 – 2020 (USD Million)
     4.1.2 Comparative Analysis: Global Biosensors Market Revenue, by Technology, 2013 & 2020 (Value %)
4.2 Electrochemical Biosensors
     4.2.1 Global Electrochemical Biosensors Market Revenue, 2012 – 2020 (USD Million)
4.3 Optical Biosensors
     4.3.1 Global Optical Biosensors Market Revenue, 2012 – 2020 (USD Million)
4.4 Piezoelectric Biosensors
     4.4.1 Global Piezoelectric Biosensors Market Revenue, 2012 – 2020 (USD Million)
4.5 Thermal Biosensors
     4.5.1 Global Thermal Biosensors Market Revenue, 2012 – 2020 (USD Million)

Chapter 5 Global Biosensors Market, by Application
5.1 Overview
     5.1.1 Global Biosensors Market Revenue, by Application, 2012 – 2020 (USD Million)
     5.1.2 Comparative Analysis: Global Biosensors Market Revenue, by Application, 2013 & 2020 (Value %)
5.2 Medical Applications
     5.2.1 Global Biosensors Market Revenue, by Medical Application, 2012 – 2020 (USD Million)
     5.2.2 Blood Glucose Monitoring
             5.2.2.1 Global Blood Glucose Monitoring Biosensors Market Revenue, 2012 – 2020 (USD Million)
     5.2.3 Blood Gas Analyzer
             5.2.3.1 Global Blood Gas Analyzer Biosensors Market Revenue, 2012 – 2020 (USD Million)
     5.2.4 Cholesterol Testing
             5.2.4.1 Global Cholesterol Testing Biosensors Market Revenue, 2012 – 2020 (USD Million)
     5.2.5 Infectious Diseases
             5.2.5.1 Global Infectious Diseases Biosensors Market Revenue, 2012 – 2020 (USD Million)
     5.2.6 Pregnancy Testing
             5.2.6.1 Global Pregnancy Testing Biosensors Market Revenue, 2012 – 2020 (USD Million)
     5.2.7 Drug Discovery
             5.2.7.1 Global Drug Discovery Biosensors Market Revenue, 2012 – 2020 (USD Million)
5.3 Food Toxicity Detection
     5.3.1 Global Food Toxicity Detection Biosensors Market Revenue, 2012 – 2020 (USD Million)
5.4 Industrial Process Control (Bioreactor)
     5.4.1 Global Industrial Process Control Biosensors Market Revenue, 2012 – 2020 (USD Million)
5.5 Agriculture
     5.5.1 Global Agricultural Testing Biosensors Market Revenue, 2012 – 2020 (USD Million)
5.6 Environment
     5.6.1 Global Environment Biosensors Market Revenue, 2012 – 2020 (USD Million)
5.7 Others (Bio-defense, drug abuse etc.)
     5.7.1 Global Other Biosensor Applications Market Revenue, 2012 – 2020 (USD Million)

Chapter 6 Global Biosensors Market, by End Users
6.1 Overview
     6.1.1 Global Biosensors Market Revenue, by End Users, 2012 – 2020 (USD Million)
     6.1.2 Comparative Analysis: Global Biosensors Market, by End Users, 2013 & 2020 (Value %)
6.2 Point of Care Testing
     6.2.1 Global POCT Biosensors Market Revenue, 2012 – 2020 (USD Million)
6.3 Home Healthcare Diagnostics
     6.3.1 Global Home Healthcare Diagnostic Biosensors Market Revenue, 2012 – 2020 (USD Million)
6.4 Research Laboratories
     6.4.1 Global Research Laboratories Biosensors Market Revenue, 2012 – 2020 (USD Million)
6.5 Security and Bio-defense
     6.5.1 Global Security and Bio-defense Biosensors Market Revenue, 2012 – 2020 (USD Million)
6.6 Food Industry
     6.6.1 Global Food Industry Biosensors Market Revenue, 2012 – 2020 (USD Million)

Chapter 7 Global Biosensors Market, by Geography
7.1 Overview
     7.1.1 Global Biosensors Market Revenue, by Geography, 2012 – 2020 (USD Million)
7.2 North America
     7.2.1 North America Biosensors Market Revenue, 2012 - 2020 (USD Million)
7.3 Europe
     7.3.1 Europe Biosensors Market Revenue, 2012 - 2020 (USD Million)
7.4 Asia Pacific
     7.4.1 Asia Pacific Biosensors Market Revenue, 2012 - 2020 (USD Million)
7.5 Rest of the World (RoW)
     7.5.1 RoW Biosensors Market Revenue, 2012 - 2020 (USD Million)

Chapter 8 Recommendations
8.1 Focus on Emerging and Developing Economies
8.2 Development of Technically Innovative Biosensor Devices to Overcome the Limitations of Existing Devices
8.3 Rigorous and Focused Research and Development (R&D) Initiatives

Chapter 9 Company Profiles
9.1 Abbott Point of Care, Inc.
     9.1.1 Company Overview
     9.1.2 Financial Overview
     9.1.3 Product Portfolio
     9.1.4 Business Strategies
     9.1.5 Recent Developments
9.2 AgaMatrix, Inc.
     9.2.1 Company Overview
     9.2.2 Financial Overview
     9.2.3 Product Portfolio
     9.2.4 Business Strategies
     9.2.5 Recent Developments
9.3 Animas Corporation
     9.3.1 Company Overview
     9.3.2 Financial Overview
     9.3.3 Product Portfolio
     9.3.4 Business Strategies
     9.3.5 Recent Developments
9.4 F. Hoffmann-La Roche Ltd.
     9.4.1 Company Overview
     9.4.2 Financial Overview
     9.4.3 Product Portfolio
     9.4.4 Business Strategies
     9.4.5 Recent Developments
9.5 LifeScan, Inc.
     9.5.1 Company Overview
     9.5.2 Financial Overview
     9.5.3 Product Portfolio
     9.5.4 Business Strategies
     9.5.5 Recent Developments
9.6 LifeSensors, Inc.
     9.6.1 Company Overview
     9.6.2 Financial Overview
     9.6.3 Product Portfolio
     9.6.4 Business Strategies
     9.6.5 Recent Developments
9.7 Medtronic, Inc.
     9.7.1 Company Overview
     9.7.2 Financial Overview
     9.7.3 Product Portfolio
     9.7.4 Business Strategies
     9.7.5 Recent Developments
9.8 Nova Biomedical Corporation
     9.8.1 Company Overview
     9.8.2 Financial Overview
     9.8.3 Product Portfolio
     9.8.4 Business Strategies
     9.8.5 Recent Developments
9.9 Siemens Healthcare
     9.9.1 Company Overview
     9.9.2 Financial Overview
     9.9.3 Product Portfolio
     9.9.4 Business Strategies
     9.9.5 Recent Developments

List of Figures

FIG. 1 Biosensors: Market Segmentation
FIG. 2 Global Biosensors Market, by Technology, 2013 (USD Million)
FIG. 3 Global Biosensors Market, by Application, 2013 (USD Million)
FIG. 4 Global Biosensors Market, by End Users, 2013 (USD Million)
FIG. 5 Comparative Analysis: Global Biosensors Market Revenue, by Geography, 2013 & 2020 (Value %)
FIG. 6 Porter’s Five Forces Analysis: Global Biosensors Market
FIG. 7 Value Chain Analysis: Global Biosensors Market
FIG. 8 Market Attractiveness Analysis: Global Biosensors Market, by Geography (2013)
FIG. 9 Comparative Analysis: Global Biosensors Market Revenue, by Technology, 2013 & 2020 (Value %)
FIG. 10 Global Electrochemical Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 11 Global Optical Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 12 Global Piezoelectric Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 13 Global Thermal Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 14 Comparative Analysis: Global Biosensors Market Revenue, by Application, 2013 & 2020 (Value %)
FIG. 15 Global Blood Glucose Monitoring Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 16 Global Blood Gas Analyzer Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 17 Global Cholesterol Testing Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 18 Global Infectious Diseases Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 19 Global Pregnancy Testing Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 20 Global Drug Discovery Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 21 Global Food Toxicity Detection Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 22 Global Industrial Process Control Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 23 Global Agricultural Testing Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 24 Global Environment Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 25 Global Other Biosensor Applications Market Revenue, 2012 – 2020 (USD Million)
FIG. 26 Comparative Analysis: Global Biosensors Market, by End Users, 2013 & 2020 (Value %)
FIG. 27 Global POCT Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 28 Global Home Healthcare Diagnostic Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 29 Global Research Laboratories Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 30 Global Security and Bio-defense Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 31 Global Food Industry Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 32 North America Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 33 Europe Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 34 Asia Pacific Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 35 RoW Biosensors Market Revenue, 2012 – 2020 (USD Million)
FIG. 36 Abbott Laboratories: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 37 F. Hoffmann-La Roche Ltd.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 38 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million)
FIG. 39 Siemens Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Biosensors Market
TABLE 2 Global Biosensors Market Revenue, by Technology, 2012 – 2020 (USD Million)
TABLE 3 Global Biosensors Market Revenue, by Application, 2012 – 2020 (USD Million)
TABLE 4 Global Biosensors Market Revenue, by Medical Application, 2012 – 2020 (USD Million)
TABLE 5 Global Biosensors Market Revenue, by End Users, 2012 – 2020 (USD Million)
TABLE 6 Global Biosensors Market Revenue, by Geography, 2012 – 2020 (USD Million)

Enquiry Before Buying


Free Market Analysis


Biosensors have emerged as the most potential analytical tools used for the detection of an analyte with the help of a physiochemical detector. Although traditional laboratory techniques can yield accurate measurements, these are extremely time- consuming, complex, expensive, and require pre-treatment of the biological sample. Biosensor-based devices provide rapid, on-site and real-time monitoring without the need for sample preparation. The increasing applications of biosensors across various fields such as drug development, medical diagnosis, food safety and environmental monitoring is driving the growth of the global biosensors market. Recent improvements in biosensor instrumentation and increasing applications of nanotechnology are the other factors contributing to the growth of the biosensors market.

Based on technology, the biosensors market has been segmented into electrochemical, optical, thermal and piezoelectric biosensors. Electrochemical biosensors accounted for the largest share of over 70% of the global biosensors market in 2013. The segment is expected to maintain its leading position during the forecast period from 2014 to 2020. Factors that have contributed toward the high market share of the electrochemical biosensors segment are the increasing applications for the detection and early diagnosis of several diseases such as diabetes and tuberculosis. Additionally, electrochemical biosensors have emerged enormously among the researchers due to high demand from the global market for the analysis of contents of a biological sample. The optical biosensors segment is estimated to grow at a CAGR of over 8%. The major driving factors for such impressive growth are increasing research in biomedical applications and pharmaceuticals; and high sensitivity, small size and cost-effectiveness of the optical biosensors. Based on applications, the biosensors market has been segmented into medical devices and diagnostics, pharmaceuticals, food and beverage, and environment. The medical application segment held the largest share of over 65% in the global biosensors market in 2013. The factors fueling the growth of the segment are high prevalence of chronic diseases across the globe and growing preference of the population for self-monitoring. Furthermore, biosensor-based diagnostic devices are a powerful alternative to conventional analytical techniques due to rapid measurement and response time. This factor further propels the growth of the medical devices and diagnostics segment. Based on end users, the point of care testing segment accounted for the largest market share owing to various factors such as better quality service, reduction patient waiting time and greater patient satisfaction.

Geographically, North America constituted the largest market for biosensors. Factors that have augmented the growth of the biosensors market in North America are vast presence of pharmaceutical research and development units, increasing prevalence of life-threatening diseases and better healthcare infrastructure. Furthermore, technological developments in the field of medical diagnostics and increasing awareness among the general population are boosting the demand for biosensors in North America. However, Asia Pacific is projected to witness the highest growth rate during the forecast period. Factors such as the large population, increasing initiatives taken by the government to promote healthcare and robust economic growth have been attributed to the high growth rate in the region. Moreover, higher consumer awareness about heath issues, environmental hazards and food toxicity would drive the growth of the biosensors market in the next few years.

Currently, the global biosensors market is consolidated due to the involvement of few top organizations. Several emerging biopharmaceutical companies are expected to foresee great development in the field of biosensors monitoring devices. Major players operating in the biosensors market are Abbott Point of Care, Inc., Medtronic, Inc., LifeScan, Inc., F. Hoffmann-La Roche Ltd., AgaMatrix, Inc., Animas Corporation, LifeSensors, Inc., Siemens Healthcare and Nova Biomedical Corporation.

global-biosensors-market

 

To get discount on this report, just click on the button below.

To receive brochure, please click on the button below.

Share This Market Study!  

Upcoming Report

Payment
Copyright @ Transparency Market Research